A Study to Evaluate the Efficacy of a Hybrid Imaging and Measurement Tool for Breast Cancer Detection and Monitoring


About this study

The purpose of this research is to optimize and evaluate the efficacy of a hybrid imaging and quantitative viscoelasticity measurement tool for breast cancer detection and monitoring.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  • Female patient volunteers aged 18 years and older 
  • Without a history of mastectomy or implants 
  • Which are identified to have findings suspicious for breast cancer, or not suspicious, and may be referred to Radiology for clinical MRI and/or ultrasound, and may have had a baseline MRI, will be candidates for enrollment
  • Have biopsy proven breast cancer and are planning to be treated with neo-adjuvant chemotherapy and had their baseline MRI and/or ultrasound. VA/SDUV/CUSE will be performed after diagnostic biopsy in this group of patients

Exclusion Criteria:

  • Having any condition that does not allow proper use of our imaging devices 
  • History of mastectomy or implants



Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Azra Alizad, M.D.

Open for enrollment

Contact information:

Cynthia Andrist



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer